Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gynecologic 3Thoracic 2Head & Neck 2Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 15Parkinson Disease 4, Autosomal Dominant Lewy Body 5Neoplasm Metastasis 3Uveal Melanoma 2Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Brain Neoplasms 1

Interventions

pembrolizumab 27Nivolumab 20atezolizumab 6Ipilimumab 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Paclitaxel 4Docetaxel 4Cyclophosphamide 4Carboplatin 4fludarabine 3avelumab 3Pemetrexed 3Interleukin-2 3tislelizumab 2epacadostat 2durvalumab 2aldesleukin 2Taxes 2Radiosurgery 2Cisplatin 2veliparib 1toripalimab 1spartalizumab 1sotigalimab 1sonidegib 1sargramostim 1regorafenib 1poly ICLC 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × lenvatinib × Dermatologic × Clear all
NCT05620134 2024-10-15

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Salubris Biotherapeutics Inc

Phase 1/2 Active not recruiting
263 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡